- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Search Results
Website Search
Found 332 Results
Dr. Paul Bannen is a dedicated medical oncologist and hematologist who has been serving the Olney community for over 20 years. He earned his medical degree from the University of Missouri – Columbia School of Medicine, completed his residency in internal medicine at the University of Texas Health Science Center, and went on to complete…
Read MoreThe Olney office of Maryland Oncology Hematology plays a vital role in serving the local community. Located in the heart of Olney, this facility provides residents with access to advanced oncology and hematology services, including chemotherapy and cutting-edge treatments. The dedicated staff works closely with patients and their families to deliver personalized treatment plans tailored to individual…
Read MoreThe Maryland Oncology Hematology Chevy Chase office offers comprehensive, patient-centered care for individuals facing cancer and blood disorders. Located in the heart of Chevy Chase, this facility provides access to board-certified oncologists and hematologists who specialize in personalized treatment plans tailored to each patient’s unique needs. With a strong commitment to compassionate care and medical…
Read MoreJessica Adams has over 15 years of nursing experience. She worked as an inpatient solid organ transplant nurse in Washington, DC where she has developed expertise in providing complex, compassionate care to patients and their families. She has worked as a Nurse Practitioner since 2024. Jessica earned her Bachelor of Science in Nursing from the…
Read MoreRandomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant versus Physician’s Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)(D9722C00001) MOA: Saruparib (AZD5305) is a selective inhibitor of PARP1, with…
Read More